Sotera Health Company (NASDAQ:SHC) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Sotera Health Company (NASDAQ:SHC) have earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $20.00.

SHC has been the subject of several research analyst reports. Wells Fargo & Company downgraded shares of Sotera Health to an “overweight” rating in a report on Thursday, January 8th. JPMorgan Chase & Co. upped their target price on Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Royal Bank Of Canada began coverage on Sotera Health in a report on Thursday, January 8th. They set an “outperform” rating and a $24.00 price target for the company. Barclays upped their price objective on Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Finally, BMO Capital Markets initiated coverage on Sotera Health in a report on Thursday, November 13th. They set an “outperform” rating and a $19.00 target price for the company.

Insiders Place Their Bets

In related news, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total value of $105,818,400.00. Following the completion of the sale, the director directly owned 22,735,301 shares in the company, valued at approximately $371,267,465.33. The trade was a 22.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Michael B. Jr. Petras sold 434,104 shares of the firm’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $16.45, for a total value of $7,141,010.80. The disclosure for this sale is available in the SEC filing. Insiders sold 29,384,104 shares of company stock worth $471,824,511 in the last quarter. 47.55% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Sotera Health

A number of large investors have recently modified their holdings of the business. Retirement Systems of Alabama raised its holdings in shares of Sotera Health by 16.9% during the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock worth $4,391,000 after buying an additional 35,974 shares in the last quarter. Exchange Traded Concepts LLC acquired a new position in Sotera Health during the fourth quarter worth about $7,739,000. True Wealth Design LLC lifted its holdings in shares of Sotera Health by 389.3% in the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after acquiring an additional 1,456 shares during the last quarter. Wealth Enhancement Advisory Services LLC bought a new stake in shares of Sotera Health during the 4th quarter valued at approximately $1,125,000. Finally, NorthCrest Asset Manangement LLC bought a new stake in shares of Sotera Health during the 4th quarter valued at approximately $183,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Price Performance

NASDAQ:SHC opened at $19.18 on Friday. Sotera Health has a 12-month low of $9.53 and a 12-month high of $19.85. The firm has a market capitalization of $5.45 billion, a price-to-earnings ratio of 100.95 and a beta of 1.82. The stock’s 50 day moving average price is $17.27 and its two-hundred day moving average price is $15.62. The company has a quick ratio of 2.18, a current ratio of 2.38 and a debt-to-equity ratio of 4.04.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, November 4th. The company reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.The business had revenue of $311.31 million for the quarter, compared to analyst estimates of $303.63 million. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. On average, analysts anticipate that Sotera Health will post 0.61 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.